MBS303, a Novel 2:1 CD20×CD3 Bispecific Antibody, Demonstrated
mbs303MBS303 is a CD20×CD3 T-cell-engaging bispecific antibody that has a novel 2:1 (CD20:CD3) confuration to kill malnant B cells. This dose-escalation phase Ⅰ trialLOGINDAFTAR MBS303 · BOCORAN JAM GACOR · DEPOSIT VIA PULSA · LINK ALTERNATIF.